Literature DB >> 19697800

Acquired left ventricular-to-right atrial shunt (Gerbode defect) due to infective endocarditis.

Nuno Cortez-Dias1, Manuel Gato Varela, João Marques, Luís Sargento, Susana Martins, Miguel Almeida Ribeiro, Ana G Almeida, A Nunes Diogo, Mário G Lopes.   

Abstract

Left ventricular-to-right atrial communications are a rare type of ventricular septal defect, known as the Gerbode defect. They are usually congenital, but rare cases have been described secondary to bacterial endocarditis. The authors present a rare case of Gerbode defect and severe pericardial effusion secondary to Staphylococcus aureus endocarditis, in a patient with alcoholic liver cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19697800

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  5 in total

Review 1.  Gerbode defect: Another nail for the 3D transesophagel echo hammer?

Authors:  Tuncay Taskesen; Andrew Fred Prouse; Steven Lewis Goldberg; Edward Allen Gill
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-14       Impact factor: 2.357

Review 2.  Acquired left ventricle-to-right atrium shunt: clinical implications and diagnostic dilemmas.

Authors:  Shi-Min Yuan
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

Review 3.  Acquired Gerbode defect following endocarditis of the tricuspid valve: a case report and literature review.

Authors:  Edvin Prifti; Fadil Ademaj; Arben Baboci; Aurel Demiraj
Journal:  J Cardiothorac Surg       Date:  2015-09-09       Impact factor: 1.637

4.  Staphylococcus aureus Endocarditis with Multivalvular Involvement Secondary to an Atrial Septal Defect.

Authors:  Vistasp Jimmy Daruwalla; Jahnavi Sagi; Hassan Tahir; Srikanth Penumetsa
Journal:  Case Rep Cardiol       Date:  2016-02-16

5.  Left ventricular to right atrial shunt (Gerbode defect): congenital versus acquired.

Authors:  Shi-Min Yuan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-09-11       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.